SCHEDULE 13G DATED JULY 16, 2019

Company

Eledon Pharmaceuticals, Inc.

Filed

July 26, 2019

Accession Number

0001013594-19-000483

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →